1
Investors
About
Curapath is a contract development and manufacturing organization (CDMO) specializing in GMP manufacturing of polymer and lipid-based drug delivery systems, supporting early-stage to commercial-stage therapeutics with a focus on non-viral gene delivery via nanoparticles.
Explore Curapath's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.